Aion Therapeutic Inc (TSE:AION) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Aion Therapeutic Inc. has announced a delay in filing its 2024 annual financial statements due to the recent acquisition of Toppen Health, Inc. and the resulting need for additional valuations and impairment testing. The company is working diligently to complete the necessary documentation and expects to file by the end of September 2024 while a management cease trade order is in place.
For further insights into TSE:AION stock, check out TipRanks’ Stock Analysis page.